LSEG named Goodwin the number one global advisor for All Private Equity Stages and Venture Capital Rounds by deal count in its Q1 2025 Global Venture Capital and Private Equity Legal Advisory League Tables. In addition, PitchBook’s Q1 2025 Global League Tables recognized Goodwin as the top firm for venture capital deals in the energy sector, for exits, and the most active in Europe for representing investors. PitchBook also highlighted Goodwin as the most active firm globally and in the US for representing companies in M&A deals.
The rankings reflect the effectiveness of Goodwin’s robust industry-specific focus and client-centric approach. The firm serves as trusted advisors to capital markets, M&A, private equity, technology, healthcare, venture capital, life sciences, real estate, financial services, and other clients across select industry verticals and geographies.
Goodwin’s Q1 2025 league table results by deal count include:
LSEG Global PE/VC
- #1 Advisor to Firm - All Private Equity Stages
- #1 Advisor to Firm - VC Rounds
- #2 Advisor to Company - All Private Equity Stages
- #2 Advisor to Firm - LBO & Related Rounds
- #3 Advisor to Company - VC Rounds
- #4 Advisor to Company - LBO & Related Rounds
PitchBook
- #1 M&A - Most active globally: companies
- #1 M&A - Most active in US: companies
- #1 Venture Capital - Exits
- #1 Venture Capital - Energy
- #1 Venture Capital - Most active in Europe: investors
- #2 Private Equity - IT
- #2 Venture Capital - Europe
- #3 All Deals Combined - Global
- #3 All Deals Combined - US
- #3 Private Equity - Other PE Deals
- #3 Venture Capital - Early stage
- #3 Venture Capital - Late stage
- #3 Venture Capital - Global
- #3 Venture Capital - US
- #3 Venture Capital - Software
- #3 Venture Capital - HC services & systems
- #3 Venture Capital - IT hardware
- #3 Venture Capital - Media
- #3 Venture Capital - Commercial products & services
- #4 All Deals Combined - Europe
- #4 M&A - Global
- #4 M&A - US
- #4 Private Equity - Buyouts
- #4 Private Equity - US
- #4 Venture Capital - HC devices & supplies
- #4 Venture Capital - Other
- #4 Venture Capital - Pharma & BioTech
- #5 Private Equity - Global